Key result
Prophylactic ICDs fail to improve survival in patients at high risk of nonsudden cardiac death.
Why the study?
Mortality reduction from prophylactic ICD therapy is not uniform and the importance of nonsudden cardiac death risk in predicting benefit is highlighted but optimal patient selection strategies remain unclear.
Does prophylactic ICD therapy improve survival in patients with reduced LVEF who are at high risk of nonsudden cardiac death?
Does prophylactic ICD therapy improve survival in patients with reduced LVEF who are at high risk of nonsudden cardiac death?
Prophylactic ICD therapy may not provide significant survival benefits for patients with reduced LVEF who are at high risk of non-sudden cardiac death, highlighting the need for better risk stratification.
No takes yet. Share an insight, caveat, or question.
May not support prophylactic ICDs in high nonsudden death risk; leaves open refined selection criteria for reduced LVEF.
Scott et al. (2011) conducted a review in Reduced left ventricular ejection fraction (LVEF) at high risk of nonsudden cardiac death. Prophylactic implantable cardioverter defibrillator (ICD) therapy was evaluated on Survival. Prophylactic ICD therapy does not provide significant survival benefit for patients at high risk of nonsudden cardiac death, irrespective of their risk of sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: